CoChat

Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study

Open access
Mejia-Chew, Carlos, O'Halloran, Jane A, Olsen, Margaret A, Stwalley, Dustin, Kronen, Ryan, Lin, Charlotte, Salazar, Ana S, Larson, Lindsey, Hsueh, Kevin, Powderly, William G, Spec, Andrej · 2019 · The Lancet Infectious Diseases
Cited by 113

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background Candida blood stream infection (BSI) is associated with high mortality. Infectious diseases (ID) consultation improves outcomes in several infections, including Staphylococcus aureus, cryptococcosis and resistant organisms. We examine the association between ID consultation for Candida BSI with mortality and differences in management. Methods In this retrospective, single-center cohort study, medical charts of all hospitalized patients ≥18 years old with Candida BSI from 2002 to 2015 were reviewed. We collected demographics, comorbidities, predisposing factors, all-cause mortality, antifungal usage, central line removal, ophthalmologic and echocardiographic evaluation to evaluate 90-day all-cause mortality between those with and without an ID consult. For the survival analysis we used Cox proportional hazards model with inverse weighting by propensity score to have an ID consult. Findings Analysis included 1,691 patients; 776 (45.9%) in the ID consult group. Most underlying comorbidities were evenly distributed between groups. Ninety-day mortality was 40.8% (690 patients). In the model with inverse weighting by the propensity score, ID consult was associated with a hazard ratio of 0.81 (95% CI: 0.73, 0.91, p<0.001) for mortality. In the consult group median duration of antifungal therapy was longer (18 vs 14 days, p<0.001) and central line removal (75.6% [587/776] vs 58.8% [538/915], p<0.001), echocardiography use (56.9% [442/776] vs 33.3% [305/915], p<0.001) and ophthalmologic examination (53.1% [412/776] vs 17.5% [160/915], p<0.001) were more frequently done. Fewer patients in the ID consult group were not treated (1.7% [13/776] vs 14% [128/915], p<0.001). Interpretation Patients with Candida BSI receiving an ID consult have lower mortality. This may be attributable to a higher receipt of non-pharmacological, evidence-based interventions and lower rate of non-treatment. These data suggest that an ID consult should be an integral part of clinical care of patients with Candida BSI. Funding Astellas Global Development Pharma, Inc., Washington University Institute of Clinical and Translational Sciences, the Agency for Healthcare Research and Quality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(19)30405-0

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 113

Metadata

Authors
Mejia-Chew, C., O'Halloran, J. A., Olsen, M. A., Stwalley, D., Kronen, R., Lin, C., Salazar, A. S., Larson, L., Hsueh, K., Powderly, W. G., & Spec, A.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2019-12
Volume
19
Issue
12
Pages
1336-1344
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2975186457
Cited by
113
References
9
FWCI
8.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study. https://app.cochat.ai/papers/10.1016/s1473-3099(19)30405-0
The paper
Mejia-Chew, C., O'Halloran, J. A., Olsen, M. A., Stwalley, D., Kronen, R., Lin, C., Salazar, A. S., Larson, L., Hsueh, K., Powderly, W. G., & Spec, A. (2019). Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(19)30405-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.